FDA Safety Reports Reassess Ultrasound Enhancing Agents Amid Pandemic Reporting Shifts
A re-analysis of FDA adverse event data from 2014 to 2024 finds that only 11.2% of the rise in serious ...
A re-analysis of FDA adverse event data from 2014 to 2024 finds that only 11.2% of the rise in serious ...
One of the most widely prescribed HIV treatments in the world is now the subject of a large-scale safety review, ...
A combined real-world cohort and FAERS analysis finds lecanemab generally safe in Alzheimer's patients but flags a strong, unlabeled signal ...
Lutetium-177-PSMA-617 (Pluvicto®) has emerged as a groundbreaking radiolabeled therapeutic agent in the battle against advanced prostate cancer, specifically targeting metastatic ...
Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, opening new horizons in the fight against malignancies by unleashing the immune ...
In recent years, chimeric antigen receptor T-cell (CAR-T) therapy has emerged as a transformative approach to treating refractory hematologic malignancies. ...
In the evolving landscape of lung cancer treatment, the integration of immune checkpoint inhibitors (ICIs) with conventional chemotherapy regimens has ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine